MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

MDSpire News

  • August 5, 2026
Respiratory Complaints Linked to Delayed Fibrotic ILD Diagnosis
  • Andrea Surnit
  • August 5, 2026
  • 4 min

Objective: To investigate the prevalence and factors associated with delayed diagnosis of fibrotic interstitial lung disease (ILD). Approach: Study Design: A re

...more

MDSpire News

  • August 5, 2026
Could Pregnancy Complications Predict CVD Risk?
  • Andrea Surnit
  • August 5, 2026
  • 4 min

Objective: To develop and validate a cardiovascular disease risk prediction model for reproductive-aged women incorporating pregnancy-related and female-specifi

...more

The Pathologist

  • August 5, 2026
Integrated Diagnostics: A Strategic Priority?
  • Chris Scarisbrick
  • August 5, 2026
  • 8 min
  1. Many UK procurement strategies still treat radiology and pathology as separate entities, despite the need for integrated diagnostics.
  2. Pathologists face increasing pressures from policy demands, while radiology also contends with growing imaging volumes and workforce shortages.
  3. Integrated diagnostics can enhance efficiency and patient outcomes by combining radiology and pathology under a single enterprise imaging platform.
  4. Separate funding models for pathology and imaging networks lead to duplicated costs and inefficiencies in healthcare delivery.
  5. Regions that prioritize integrated diagnostics have shown improved outcomes, highlighting the potential benefits of a unified approach.
...more

The Pathologist

  • August 5, 2026
ADLM 2026: Diabetes Test Bias May Mask Risk
  • August 5, 2026
  • 2 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

The Ophthalmologist

  • August 5, 2026
Could Electrical Stimulation Help Dry Eye?
  • August 5, 2026
  • 3 min
  1. Dry eye disease involves multiple factors, including tear film instability and meibomian gland dysfunction.
  2. Transcutaneous electrical stimulation (TCES) may improve blinking efficiency, addressing an under-addressed aspect of dry eye.
  3. The review discusses various TCES technologies, including transcutaneous electrical nerve stimulation and dynamic muscle stimulation.
  4. Ophthalmic studies indicate TCES may enhance tear film stability and reduce ocular discomfort in dry eye patients.
  5. The authors emphasize that while promising, the evidence for TCES in dry eye management is still in early stages.
...more

The Ophthalmologist

  • August 5, 2026
Erucamide and the Degenerating Retina
  • August 5, 2026
  • 3 min

Objective: To investigate the role of erucamide in protecting the degenerating retina and its potential therapeutic applications. Approach: Metabolomics Screeni

...more

The Analytical Scientist

  • August 5, 2026
Imagining the Tools of Tomorrow
  • August 5, 2026
  • 14 min
  1. Christina Fan, PhD, transitioned from aspiring medical doctor to bioengineer, influenced by her physician parents and a passion for hands-on problem-solving.
  2. Fan's significant early discovery involved using digital PCR for chromosome counting, leading to the development of non-invasive prenatal testing (NIPT) in 2008.
  3. Her work combined digital counting with next-generation sequencing to detect fetal DNA in maternal plasma, addressing challenges in prenatal screening.
  4. Fan emphasizes the importance of perspective and collaboration, advocating for innovative approaches and tools beyond traditional methods in scientific research.
  5. Driven by a desire to make scientific advancements accessible, Fan moved from academia to industry, focusing on the commercialization of innovative technologies.
...more

The Analytical Scientist

  • August 5, 2026
Mass Spec Roundup: DNA, DART, and Damage Repair
  • August 5, 2026
  • 6 min
  1. Nanoparticle-enriched mass spectrometry identified over 600 genetic associations with plasma proteins in British South Asian volunteers.
  2. The study detected more than 5,700 protein groups, with mass spectrometry revealing over 3,400 proteins not identified by affinity assays.
  3. Integration with biobank data linked 21 proteins to 44 diseases, highlighting the importance of analytical diversity in genetic studies.
  4. A new SEC–ICP-MS workflow quantified synthetic DNA fragments without digestion, improving selectivity and accuracy in DNA measurement.
  5. The PERM-DART-MS method enhanced reproducibility in direct mass spectrometry analysis while minimizing contamination and thermal damage.
...more

The Medicine Maker

  • August 5, 2026
How China Is Rewriting the Rules Global Drug Development
  • James Strachan
  • August 5, 2026
  • 16 min
  1. China's biopharma ecosystem has evolved from a generics-focused market to a globally influential engine for innovation and clinical development.
  2. Regulatory reforms in China have significantly reduced drug approval timelines, enabling companies to obtain IND approval in about 30 working days.
  3. China accounted for 32.3% of global drug-development program originations in 2024, with increasing partnerships from major pharma companies.
  4. Chinese companies are recognized leaders in developing modalities like cell and gene therapy and antibody-drug conjugates, influencing global drug development.
  5. China's integrated biopharma ecosystem promotes faster decision-making and efficiency, challenging traditional Western drug development assumptions.
...more

Dana-Farber

  • August 4, 2026
U.S. News & World Report Names Dana-Farber Brigham Cancer Center #1 Locally, #3 Nationally for 2026-2027
  • August 4, 2026
  • 2 min
  1. Dana-Farber Brigham Cancer Center is ranked #1 in Massachusetts and #3 nationally for cancer care by U.S. News & World Report.
  2. This marks the 26th consecutive year Dana-Farber Brigham has been recognized for excellence in cancer care.
  3. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions.
  4. Only 16% of evaluated hospitals received a Best Hospitals designation from U.S. News.
  5. The ranking reflects Dana-Farber's commitment to high-quality care and successful patient outcomes.
...more

The Medicine Maker

  • August 4, 2026
The 10 Biggest Bottlenecks Slowing Drug Development
  • August 4, 2026
  • 8 min
  1. Patient recruitment for clinical trials is a significant bottleneck, necessitating a balance between scientific rigor and practical considerations.
  2. The complexity of clinical trials has increased, making patient recruitment more challenging due to evolving regulatory requirements and specific inclusion criteria.
  3. Boards and executives must adapt to the intensified competition in drug development, as outdated strategies hinder funding opportunities.
  4. Accurate measurement of target engagement in tissues is crucial, as current reliance on plasma-based assays limits the ability to address underlying challenges.
  5. Translational predictability remains a major bottleneck, especially for neurodegenerative diseases, due to reliance on inadequate model systems.
...more

MDSpire News

  • August 4, 2026
PM2.5 Exposure May Be Linked to Lewy Dementias
  • Andrea Surnit
  • August 4, 2026
  • 3 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 4, 2026
QOL After Head and Neck Reconstruction
  • Andrea Surnit
  • August 4, 2026
  • 3 min

Objective: To evaluate the quality of life (QOL) trajectories in patients undergoing head and neck reconstruction beyond the first postoperative year. Approach:

...more

MDSpire News

  • August 4, 2026
Distribution Barriers May Reduce Biologic Drug Survival
  • Andrea Surnit
  • August 4, 2026
  • 3 min
  1. Distribution barriers may reduce biologic drug survival among patients with moderate-to-severe psoriasis.
  2. Patients reporting medication distribution problems were more likely to discontinue biologic therapy.
  3. Adalimumab was the most frequently prescribed biologic, followed by secukinumab and ustekinumab.
  4. Approximately one-third of patients reported their biologic medication was out of stock during therapy.
  5. The study acknowledged limitations due to its retrospective design and small sample size.
...more

MDSpire News

  • August 4, 2026
Uncovering Persistent Pain Pattern in Gout
  • Andrea Surnit
  • August 4, 2026
  • 4 min
  1. About one-third of gout patients report a constant pain pattern, differing from the traditional intermittent flare model.
  2. The study analyzed data from 90 adult patients with physician-diagnosed gout who experienced at least two flares in the previous six months.
  3. Independent factors associated with constant pain included younger age at gout onset, greater activity limitation, and current anxiety or depression.
  4. Patients with greater activity limitation had nearly six times the odds of reporting constant pain compared to those with intermittent pain.
  5. The study's cross-sectional design limits causal inference, and findings may not generalize to all gout patients due to recruitment criteria.
...more

Inside Dentistry

  • August 4, 2026
Three DEXIS Solutions Earn Digital Dentistry Society Certification
  • Inside Dentistry Staff
  • August 4, 2026
  • 2 min
  1. DEXIS announced that three of its digital dentistry solutions received certification from the Digital Dentistry Society.
  2. The certified solutions include DEXIS™ Imprevo™, ORTHOPANTOMOGRAPH™ OP 3D™ LX, and DTX Studio™ Clinic.
  3. Certification criteria focused on safety, usability, and clinical relevance as evaluated by the Digital Dentistry Society.
  4. The certified products are designed to function as part of a unified digital workflow for imaging and diagnostics.
  5. DEXIS is part of the Envista family and offers dental imaging technologies integrated within a connected digital workflow.
...more

MDSpire News

  • August 4, 2026
An Overlooked Cause of Pediatric Anaphylaxis
  • Teraya Smith
  • August 4, 2026
  • 3 min
  1. Spice allergy is a potential cause of pediatric anaphylaxis, particularly during cooking rather than after eating.
  2. The first reported case of cumin-induced anaphylaxis from inhalation involved a 17-year-old girl with a history of allergic conditions.
  3. Spices accounted for 4% of anaphylaxis cases in children in a 2016 European registry and 0.7% in a 2023 analysis.
  4. The study highlighted the need for better skin testing standardization to reduce false-positive results in spice allergy diagnosis.
  5. Clinical history is crucial for diagnosing spice allergies, which may be overlooked without thorough investigation.
...more

The Ophthalmologist

  • August 4, 2026
GA Treatment Preferences
  • August 4, 2026
  • 4 min

Objective: To quantitatively assess retina specialists' preferences for geographic atrophy (GA) treatment options. Approach: Study Design: A best-best discrete

...more